{"id":"https://openalex.org/W2965138349","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2510","title":"Characterization of the exposure-response relationship leading to recommendations for dosing optimization in a new drug application review.","display_name":"Characterization of the exposure-response relationship leading to recommendations for dosing optimization in a new drug application review.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2965138349","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2510","mag":"2965138349"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.2510","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2510","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2510","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061426227","display_name":"Jun Yang","orcid":"https://orcid.org/0000-0002-4233-3220","observed_orcids":["https://orcid.org/0000-0002-4233-3220"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Yang","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028489187","display_name":"Nitin Mehrotra","orcid":"https://orcid.org/0000-0002-9415-2720","observed_orcids":["https://orcid.org/0000-0002-9415-2720"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitin Mehrotra","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100675711","display_name":"Hong Zhao","orcid":"https://orcid.org/0000-0003-4616-3123","observed_orcids":["https://orcid.org/0000-0003-4616-3123","https://orcid.org/0009-0003-0543-2689","https://orcid.org/0009-0008-0111-7995"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hong Zhao","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027658438","display_name":"Ruthann M. Giusti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruthann Marie Giusti","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069834954","display_name":"Suzanne Demko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne Demko","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077268765","display_name":"Patricia Keegan","orcid":"https://orcid.org/0000-0002-7266-395X","observed_orcids":["https://orcid.org/0000-0002-7266-395X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Keegan","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112102258","display_name":"Brian P. Booth","orcid":"https://orcid.org/0009-0002-3812-4060","observed_orcids":["https://orcid.org/0009-0002-3812-4060"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Booth","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009175693","display_name":"Nam Atiqur Rahman","orcid":"https://orcid.org/0009-0001-0002-7006","observed_orcids":["https://orcid.org/0009-0001-0002-7006"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nam Atiqur Rahman","raw_affiliation_strings":["U.S. Food and Drug Administration, Silver Spring, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1320320070"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"2510","last_page":"2510"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.37229999899864197,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.37229999899864197,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.2484000027179718,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.1881999969482422,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":1.0},{"id":"https://openalex.org/keywords/exposure-response-analysis","display_name":"exposure-response analysis","score":0.7200000286102295},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.6959999799728394},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8849999904632568},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.8080000281333923},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6710000038146973},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.7570000290870667},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9033356308937073},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.8674620389938354},{"id":"https://openalex.org/C2780120053","wikidata":"https://www.wikidata.org/wiki/Q3493538","display_name":"Medullary thyroid cancer","level":4,"score":0.5774369239807129},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5475791096687317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5314791202545166},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5231655836105347},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.506164014339447},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5046554803848267},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.44644805788993835},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4335373640060425},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3774570822715759},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.32650232315063477},{"id":"https://openalex.org/C2779761222","wikidata":"https://www.wikidata.org/wiki/Q826522","display_name":"Thyroid cancer","level":3,"score":0.2611626982688904},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11245182156562805},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.2510","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2510","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2510","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3038052879","https://openalex.org/W2801596150","https://openalex.org/W801104115","https://openalex.org/W4315436293","https://openalex.org/W4214842829","https://openalex.org/W3202477645","https://openalex.org/W4323050705","https://openalex.org/W2794235253","https://openalex.org/W2602809318","https://openalex.org/W4324136911"],"abstract_inverted_index":{"2510":[0],"Background:":[1],"On":[2],"November":[3],"29":[4],"2012,":[5],"the":[6,14,49,58,61,68,79,82,127,131,234,244,271,278,295],"U.":[7],"S.":[8],"FDA":[9,284],"approved":[10],"cabozantinib":[11,63,83,137,172,302],"(COMETRIQ)":[12],"for":[13,67,106,167,203],"treatment":[15,69],"of":[16,32,51,70,81,165,170,205,211,233,247,299],"patients":[17,100,176,218,227],"with":[18,101,177,182,207,219,228,262,270],"progressive,":[19],"metastatic":[20,102],"medullary":[21],"thyroid":[22],"cancer":[23],"(MTC).":[24],"Drug-related":[25],"toxicity":[26],"was":[27,65,124],"common":[28],"at":[29],"a":[30,200,208,255,288,300],"dose":[31,64,112,157,223,248,257],"140":[33],"mg":[34],"once":[35],"daily":[36],"across":[37],"Phase":[38,41],"1":[39],"to":[40,77,111,156,240,243,282,286,293],"3":[42],"trials":[43,280],"submitted":[44],"in":[45,130,277],"this":[46,52],"NDA.":[47],"During":[48],"review":[50],"application,":[53],"these":[54,251],"safety":[55,146,273,296],"findings":[56],"raised":[57],"question":[59],"whether":[60],"optimal":[62],"selected":[66,145],"MTC.":[71,103],"Exposure-response":[72],"(E-R)":[73],"analyses":[74,164,236,268],"were":[75,88,160],"performed":[76],"assess":[78],"appropriateness":[80],"dose.":[84,303],"Methods:":[85],"The":[86,134,190,231,266],"data":[87,276],"obtained":[89],"from":[90],"an":[91,283],"international,":[92],"multi-center,":[93],"randomized":[94],"(2:1),":[95],"placebo-controlled":[96],"trial":[97,292],"enrolling":[98],"330":[99],"To":[104],"account":[105],"variable":[107],"exposure":[108,119,128,138,173,179,184],"levels":[109],"due":[110,242],"modification":[113,158,224],"and":[114,139,144,154,180,274,297],"inter-individual":[115],"pharmacokinetic":[116],"variability,":[117],"average":[118,171],"(Starting":[120],"Dose*Dose":[121],"intensity/individual":[122],"CL/F)":[123],"used":[125],"as":[126,199,260],"metric":[129],"E-R":[132,235,267],"analyses.":[133],"relationships":[135],"between":[136],"progression":[140],"free":[141],"survival":[142],"(PFS),":[143],"endpoints":[147],"including":[148],"diarrhea,":[149],"palmar-plantar":[150],"erythrodysesthesia":[151],"(PPE)":[152],"syndrome":[153],"time":[155],"(TTDM)":[159],"evaluated.":[161],"Results:":[162],"Kaplan-Meier":[163],"PFS":[166],"each":[168],"quartile":[169],"suggest":[174],"that":[175,217,254],"lower":[178,229,256,301],"those":[181],"higher":[183,220],"may":[185,237,258],"have":[186],"equivalent":[187],"PFS,":[188],"comparatively.":[189],"multivariate":[191],"Cox":[192],"proportional":[193],"analysis":[194],"identified":[195],"individual":[196],"patient\u2019s":[197],"clearance":[198],"significant":[201],"covariate":[202],"prediction":[204],"TTDM":[206],"hazard":[209],"ratio":[210],"1.95":[212],"(95%":[213],"CI":[214],"[1.47-2.59]),":[215],"suggesting":[216],"exposures":[221],"required":[222],"earlier":[225],"than":[226],"exposures.":[230],"results":[232,252],"be":[238,259],"difficult":[239],"interpret":[241],"high":[245],"rate":[246],"modification.":[249],"Nevertheless,":[250],"indicate":[253],"effective":[261],"improved":[263],"tolerability.":[264],"Conclusions:":[265],"along":[269],"observed":[272],"efficacy":[275,298],"clinical":[279,291],"led":[281],"requirement":[285],"conduct":[287],"post":[289],"marketing":[290],"evaluate":[294]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-05T09:50:58.205359","created_date":"2019-08-13T00:00:00"}